Viracta Therapeutics Inc (NASDAQ:VIRX)
| 1.32 BATS BZX Real-Time Price As of 10:25am ET |  0.00 / 0.00%Today’s Change | 0.88 Today|||52-Week Range 5.75 | -9.59% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 3.1M | 2.5M | 669.0K | 237.0K | |
| Depreciation And Amortization | 27.0K | 11.0K | 9.0K | 9.0K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 42.3M | 39.0M | 35.1M | 25.9M | ||
| Research And Development | 23.7M | 22.9M | 21.5M | 14.6M | ||
| Total Operating Expenses | 42.4M | 39.0M | 35.1M | 25.9M | ||
| Non-Operating Expenses | Operating Income | -39.3M | -36.5M | -34.4M | -25.7M | |
| Extraordinary Credit | 3.5M | 0.00 | 0.00 | 0.00 | ||
| Interest Expense On Debt | 939.0K | 1.7M | 1.4M | 1.2M | ||
| Other Expenses | 22.0K | 158.0K | 357.0K | 249.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -36.7M | -38.0M | -35.5M | -26.6M | |
| Net Income | -36.7M | -38.0M | -35.5M | -26.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 12.2M | 15.7M | 24.5M | 35.6M | |
| Shares To Calculate EPS Diluted | 12.2M | 15.7M | 24.5M | 35.6M | ||
| Earnings Per Share | EPS | -$3.00 | -$2.42 | -$1.45 | -$0.75 | |
| EPS Diluted | -$3.00 | -$2.42 | -$1.45 | -$0.75 | ||
